# General Motors Co: financial statements, quarterly

GM · NYSE · CIK 1467858 · [Consumer discretionary](/sectors/consumer-discretionary.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/gm.md) · [Financials](/companies/gm/financials.md) · [Filings](/companies/gm/filings.md) · [Insiders](/companies/gm/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/gm/financials.md?period=annual).

## Income statement

| Line item | Unit | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $bn | [39.3 d](/filings/0001467858-26-000013.md) | [39.2](/filings/0001467858-25-000096.md) | [44.1](/filings/0001467858-25-000121.md) | [44.7](/filings/0001467858-25-000143.md) | [43.6 d](/filings/0001467858-26-000013.md) | [39.9](/filings/0001467858-26-000035.md) | [42.9](/filings/0001467858-26-000051.md) | [44.3](/filings/0001467858-26-000059.md) | [41.0 d](/filings/0001467858-26-000013.md) | [39.3](/filings/0001467858-26-000035.md) | [43.8](/filings/0001467858-26-000051.md) | [45.7](/filings/0001467858-26-000059.md) |
| Cost of revenue | $bn | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Gross profit | $bn | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Selling, general and administrative | $bn | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Operating income | $bn | [0.9 d](/filings/0001467858-26-000013.md) | [3.7](/filings/0001467858-25-000096.md) | [3.9](/filings/0001467858-25-000121.md) | [3.7](/filings/0001467858-25-000143.md) | [1.5 d](/filings/0001467858-26-000013.md) | [3.4](/filings/0001467858-26-000035.md) | [2.1](/filings/0001467858-26-000051.md) | [1.1](/filings/0001467858-26-000059.md) | [(3.6) d](/filings/0001467858-26-000013.md) | [2.9](/filings/0001467858-26-000035.md) | [1.5](/filings/0001467858-26-000051.md) | [3.6](/filings/0001467858-26-000059.md) |
| Interest expense | $bn | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $bn | [(0.9) d](/filings/0001467858-26-000013.md) | [0.8](/filings/0001467858-25-000096.md) | [0.8](/filings/0001467858-25-000121.md) | [0.7](/filings/0001467858-25-000143.md) | [0.3 d](/filings/0001467858-26-000013.md) | [0.7](/filings/0001467858-26-000035.md) | [0.5](/filings/0001467858-26-000051.md) | [0.1](/filings/0001467858-26-000059.md) | [(1.0) d](/filings/0001467858-26-000013.md) | [0.6](/filings/0001467858-26-000035.md) | [0.2](/filings/0001467858-26-000051.md) | [0.6](/filings/0001467858-26-000059.md) |
| Net income | $bn | [2.1 d](/filings/0001467858-26-000013.md) | [3.0](/filings/0001467858-25-000096.md) | [2.9](/filings/0001467858-25-000121.md) | [3.1](/filings/0001467858-25-000143.md) | [(3.0) d](/filings/0001467858-26-000013.md) | [2.8](/filings/0001467858-26-000035.md) | [1.9](/filings/0001467858-26-000051.md) | [1.3](/filings/0001467858-26-000059.md) | [(3.3) d](/filings/0001467858-26-000013.md) | [2.6](/filings/0001467858-26-000035.md) | [1.3](/filings/0001467858-26-000051.md) | [3.3](/filings/0001467858-26-000059.md) |
| Diluted EPS | $ per share | not reported | [2.56](/filings/0001467858-25-000096.md) | [2.55](/filings/0001467858-25-000121.md) | [2.68](/filings/0001467858-25-000143.md) | not reported | [3.35](/filings/0001467858-26-000035.md) | [1.91](/filings/0001467858-26-000051.md) | [1.35](/filings/0001467858-26-000059.md) | not reported | [2.82](/filings/0001467858-26-000035.md) | [1.41](/filings/0001467858-26-000051.md) | [3.73](/filings/0001467858-26-000059.md) |
| Basic EPS | $ per share | not reported | [2.57](/filings/0001467858-25-000096.md) | [2.57](/filings/0001467858-25-000121.md) | [2.71](/filings/0001467858-25-000143.md) | not reported | [3.40](/filings/0001467858-26-000035.md) | [1.94](/filings/0001467858-26-000051.md) | [1.37](/filings/0001467858-26-000059.md) | not reported | [2.87](/filings/0001467858-26-000035.md) | [1.44](/filings/0001467858-26-000051.md) | [3.79](/filings/0001467858-26-000059.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: not reported
- Gross profit: not reported
- Selling, general and administrative: not reported
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: not reported
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | [18.9](/filings/0001467858-25-000032.md) | [17.6](/filings/0001467858-24-000076.md) | [22.5](/filings/0001467858-24-000102.md) | [23.7](/filings/0001467858-24-000117.md) | [19.9](/filings/0001467858-26-000013.md) | [20.6](/filings/0001467858-25-000096.md) | [22.4](/filings/0001467858-25-000121.md) | [22.9](/filings/0001467858-25-000143.md) | [20.9](/filings/0001467858-26-000059.md) | [19.8](/filings/0001467858-26-000035.md) | [20.1](/filings/0001467858-26-000051.md) | [23.2](/filings/0001467858-26-000059.md) |
| Current assets | $bn | [102](/filings/0001467858-25-000032.md) | [106](/filings/0001467858-24-000076.md) | [112](/filings/0001467858-24-000102.md) | [115](/filings/0001467858-24-000117.md) | [109](/filings/0001467858-26-000013.md) | [110](/filings/0001467858-25-000096.md) | [114](/filings/0001467858-25-000121.md) | [115](/filings/0001467858-25-000143.md) | [109](/filings/0001467858-26-000059.md) | [109](/filings/0001467858-26-000035.md) | [110](/filings/0001467858-26-000051.md) | [116](/filings/0001467858-26-000059.md) |
| Total assets | $bn | [273](/filings/0001467858-26-000013.md) | [277](/filings/0001467858-25-000096.md) | [283](/filings/0001467858-25-000121.md) | [289](/filings/0001467858-25-000143.md) | [280](/filings/0001467858-26-000013.md) | [282](/filings/0001467858-26-000035.md) | [289](/filings/0001467858-26-000051.md) | [288](/filings/0001467858-26-000059.md) | [281](/filings/0001467858-26-000059.md) | [281](/filings/0001467858-26-000035.md) | [283](/filings/0001467858-26-000051.md) | [289](/filings/0001467858-26-000059.md) |
| Current liabilities | $bn | [94.4](/filings/0001467858-25-000032.md) | [91.8](/filings/0001467858-24-000076.md) | [95.4](/filings/0001467858-24-000102.md) | [95.5](/filings/0001467858-24-000117.md) | [96.3](/filings/0001467858-26-000013.md) | [90.7](/filings/0001467858-25-000096.md) | [93.8](/filings/0001467858-25-000121.md) | [93.3](/filings/0001467858-25-000143.md) | [93.3](/filings/0001467858-26-000059.md) | [94.7](/filings/0001467858-26-000035.md) | [96.8](/filings/0001467858-26-000051.md) | [106](/filings/0001467858-26-000059.md) |
| Total liabilities | $bn | [205](/filings/0001467858-25-000032.md) | [206](/filings/0001467858-24-000076.md) | [211](/filings/0001467858-24-000102.md) | [215](/filings/0001467858-24-000117.md) | [214](/filings/0001467858-26-000013.md) | [216](/filings/0001467858-25-000096.md) | [221](/filings/0001467858-25-000121.md) | [220](/filings/0001467858-25-000143.md) | [218](/filings/0001467858-26-000059.md) | [216](/filings/0001467858-26-000035.md) | [219](/filings/0001467858-26-000051.md) | [225](/filings/0001467858-26-000059.md) |
| Shareholders' equity | $bn | [64.3](/filings/0001467858-25-000032.md) | [66.6](/filings/0001467858-24-000076.md) | [68.6](/filings/0001467858-24-000102.md) | [70.9](/filings/0001467858-24-000117.md) | [63.1](/filings/0001467858-26-000013.md) | [64.4](/filings/0001467858-25-000096.md) | [66.4](/filings/0001467858-25-000121.md) | [66.4](/filings/0001467858-25-000143.md) | [61.1](/filings/0001467858-26-000059.md) | [62.7](/filings/0001467858-26-000035.md) | [62.0](/filings/0001467858-26-000051.md) | [62.8](/filings/0001467858-26-000059.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [3,657 d](/filings/0001467858-26-000013.md) | [3,152](/filings/0001467858-25-000096.md) | [5,976 d](/filings/0001467858-25-000121.md) | [6,861 d](/filings/0001467858-25-000143.md) | [4,140 d](/filings/0001467858-26-000013.md) | [6,061](/filings/0001467858-26-000035.md) | [6,908 d](/filings/0001467858-26-000051.md) | [7,103 d](/filings/0001467858-26-000059.md) | [6,795 d](/filings/0001467858-26-000013.md) | [2,950](/filings/0001467858-26-000035.md) | [6,354 d](/filings/0001467858-26-000051.md) | [7,316 d](/filings/0001467858-26-000059.md) |
| Capital expenditure | $m | [3,706 d](/filings/0001467858-26-000013.md) | [2,783](/filings/0001467858-25-000096.md) | [2,569 d](/filings/0001467858-25-000121.md) | [2,245 d](/filings/0001467858-25-000143.md) | [3,233 d](/filings/0001467858-26-000013.md) | [1,816](/filings/0001467858-26-000035.md) | [2,137 d](/filings/0001467858-26-000051.md) | [2,130 d](/filings/0001467858-26-000059.md) | [3,220 d](/filings/0001467858-26-000013.md) | [1,512](/filings/0001467858-26-000035.md) | [1,942 d](/filings/0001467858-26-000051.md) | [2,346 d](/filings/0001467858-26-000059.md) |
| Dividends paid | $m | [104 d](/filings/0001467858-26-000013.md) | [198](/filings/0001467858-25-000096.md) | [136 d](/filings/0001467858-25-000121.md) | [192 d](/filings/0001467858-25-000143.md) | [127 d](/filings/0001467858-26-000013.md) | [175](/filings/0001467858-26-000035.md) | [144 d](/filings/0001467858-26-000051.md) | [200 d](/filings/0001467858-26-000059.md) | [138 d](/filings/0001467858-26-000013.md) | [223](/filings/0001467858-26-000035.md) | [608 d](/filings/0001467858-26-000051.md) | [215 d](/filings/0001467858-26-000059.md) |
| Share repurchases | $m | [9,996 d](/filings/0001467858-26-000013.md) | [280](/filings/0001467858-25-000096.md) | [1,066 d](/filings/0001467858-25-000121.md) | [1,032 d](/filings/0001467858-25-000143.md) | [4,686 d](/filings/0001467858-26-000013.md) | [2,012](/filings/0001467858-26-000035.md) | [0.0 d](/filings/0001467858-26-000051.md) | [1,500 d](/filings/0001467858-26-000059.md) | [2,500 d](/filings/0001467858-26-000013.md) | [800](/filings/0001467858-26-000035.md) | [2,000 d](/filings/0001467858-26-000051.md) | [2,501 d](/filings/0001467858-26-000059.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividends
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [1,402](/filings/0001467858-24-000076.md) | [1,389](/filings/0001467858-24-000102.md) | [1,378](/filings/0001467858-24-000117.md) | [1,162](/filings/0001467858-25-000096.md) | [1,147](/filings/0001467858-25-000121.md) | [1,131](/filings/0001467858-25-000143.md) | [1,002](/filings/0001467858-26-000035.md) | [976](/filings/0001467858-26-000051.md) | [964](/filings/0001467858-26-000059.md) | [926](/filings/0001467858-26-000035.md) | [910](/filings/0001467858-26-000051.md) | [887](/filings/0001467858-26-000059.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 843,549,423 at 2026-10-09, from the cover of the [10-Q filed 2026-10-20](/filings/0001467858-26-000059.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:40 ET. No prices; not investment advice.